These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36054407)

  • 1. CD56 and smooth muscle actin immunoreactivity in basal cell carcinomas: Are they indicators of differentiation or do they hold a diagnostic use?
    Yirmibeş S; Adım ŞB; Saraydaroğlu Ö
    J Cutan Pathol; 2023 Jan; 50(1):56-61. PubMed ID: 36054407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of CD56 and Smooth Muscle Actin Expression in Basal and Squamous Cell Carcinomas.
    Yirmibes S; Balaban Adim S
    Am J Dermatopathol; 2023 Dec; 45(12):816-819. PubMed ID: 37982465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
    BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56 expression in basaloid anal squamous cell carcinoma - A potential diagnostic pitfall.
    Madahian S; Judelson R; Zhu X; Meng X; Dresser K; Hutchinson L; Bledsoe JR
    Ann Diagn Pathol; 2021 Aug; 53():151758. PubMed ID: 33989959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible Histopathologic Features in Cases of Basal Cell Carcinoma With Neuroendocrine Expression: A Clinicopathologic Study of 24 Cases With a Potential Diagnostic Pitfall.
    Plaza JA; Pootrakul L; Raghavan SS; Sangueza M; Gru AA
    Am J Dermatopathol; 2021 Dec; 43(12):903-907. PubMed ID: 34783706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NCAM (CD56), chromogranin A, synaptophysin, c-KIT (CD117) and PDGFRA in normal non-neoplastic skin and basal cell carcinoma: an immunohistochemical study of 66 consecutive cases.
    Terada T
    Med Oncol; 2013 Mar; 30(1):444. PubMed ID: 23292839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eyelid basal cell carcinoma with neuroendocrine differentiation: a case report and literature review.
    Chung IY; McKelvie P; Chen Y
    Orbit; 2021 Aug; 40(4):316-319. PubMed ID: 32586182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in basal cell carcinoma. An immunohistochemical study.
    George E; Swanson PE; Wick MR
    Am J Dermatopathol; 1989 Apr; 11(2):131-5. PubMed ID: 2469342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.
    Pilloni L; Bianco P; Manieli C; Senes G; Coni P; Atzori L; Aste N; Faa G
    Eur J Histochem; 2009; 53(2):e14. PubMed ID: 19683985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
    Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
    Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy Outcome.
    Mørk E; Mjønes P; Foss OA; Bachmann IM; Christensen E
    J Histochem Cytochem; 2023 Mar; 71(3):111-120. PubMed ID: 36961748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine expression markers in triple-negative, luminal-A, luminal-B and HER2neu breast cancer].
    Barboza-García YG; Ramírez-Balderrama L; Murguía-Pérez M; Hernández-González MA; Landeros-Navarro IY
    Rev Med Inst Mex Seguro Soc; 2024 Jan; 62(1):1-7. PubMed ID: 39110839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin.
    D'Addario SF; Morgan M; Talley L; Smoller BR
    J Cutan Pathol; 2002 Aug; 29(7):426-9. PubMed ID: 12139638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Matrix Metalloproteinases 7 and 9, Desmin, Alpha-Smooth Muscle Actin and Caldesmon, in Odontogenic Keratocyst Associated with NBCCS, Recurrent and Sporadic Keratocysts.
    Loreto C; Polizzi A; Filetti V; Pannone G; Dos Santos JN; Venezia P; Leonardi R; Isola G
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle cell neoplasms.
    Beck EM; Bauman TM; Rosman IS
    J Cutan Pathol; 2018 Aug; 45(8):581-587. PubMed ID: 29687929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
    Machado I; Navarro S; López-Guerrero JA; Verdini L; Picci P; Giner F; Llombart-Bosch A
    Pathol Res Pract; 2021 Mar; 219():153362. PubMed ID: 33610950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.